Community and Faith-Based Initiatives |
|
|
Clinical Trial: Acceptance-Based Treatment for Generalized Anxiety Disorder
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to develop and implement an integrative treatment that involves the awareness and acceptance of different emotions for the treatment of generalized anxiety disorder.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Anxiety Disorders | Behavior: Acceptance-Based Behavioral Therapy | Phase I |
MedlinePlus related topics: Anxiety
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Placebo Control, Parallel Assignment, Efficacy Study
Official Title: Developing of New Therapy for GAD: Acceptance-Based CBT
Expected Total Enrollment: 56
Study start: May 2002
Participants in this study are recruited from intakes at the Center for Anxiety and Related Disorders at Boston University. Participants will be randomly assigned to receive either acceptance and mindfulness-based strategies plus cognitive behavioral therapy or no treatment for 16 weeks. The treatment will involve daily practice of mindfulness techniques to help draw attention to and accept various emotional states. Interviews, questionnaires, and depression and anxiety scales will be used to assess participants. Assessments will be conducted post-treatment and at 3- and 9-month follow-up visits.
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Generalized Anxiety Disorder (GAD)
- Willing to maintain medication levels and refrain from any additional psychosocial treatment during the course of the study
Exclusion Criteria:
- Bipolar disorder, psychotic disorder, or substance dependence
Location and Contact Information
Massachusetts
Center for Anxiety and Related Disorders, Boston, Massachusetts, United States; Recruiting
Lizabeth Roemer, PhD, Principal Investigator
Susan M. Orsillo, PhD, Principal Investigator
More Information
Record last reviewed: November 2004
Last Updated: November 9, 2004
Record first received: December 2, 2003
ClinicalTrials.gov Identifier: NCT00073632
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 8, 2005

Not Signed In -


